Status:
RECRUITING
Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
Lead Sponsor:
Assiut University
Conditions:
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18-80 years
Brief Summary
To evaluate the role of regulatory B cells in the pathogenesis of metabolic associated fatty liver disease patients.
Detailed Description
The prevalence of non-alcoholic fatty liver disease (NAFLD) increases rapidly in recent decades. NAFLD has become a major public health problem in the whole world, and it is considered as the main cau...
Eligibility Criteria
Inclusion
- All patients aged \>18 years old and was diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques.
Exclusion
- 1-Patients aged ≤18 years old. 2-Pregnancy. 3-Presence of malignancy. 4-Type I DM. 5-Fatty liver patients on treatment by statin derivatives or other medications. 6- Fatty liver patients undergone bariatric surgeries.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT04720560
Start Date
December 1 2023
End Date
December 1 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicine
Asyut, Egypt